Company Overview of PharmEste s.r.l.
PharmEste s.r.l., a biopharmaceutical company, focuses on the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain. The company was founded in 2003 and is based in Bresso, Italy.
Via Ariosto 21
Bresso, MI 20091
Founded in 2003
39 02 66 52 45 50
39 02 66 52 45 47
Key Executives for PharmEste s.r.l.
PharmEste s.r.l. Key Developments
Similar Private Companies By Industry
|Medestea Internazionale Srl||Europe|
|CFS Europe SpA||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- Princeton, NJ | RGPPosted: Oct 21
- Parsippany, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact PharmEste s.r.l., please visit www.pharmeste.com. Company data is provided by Capital IQ. Please use this form to report any data issues.